Does LANSOPRAZOLE Cause Mobility decreased? 223 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 223 reports of Mobility decreased have been filed in association with LANSOPRAZOLE (Lansoprazole). This represents 0.4% of all adverse event reports for LANSOPRAZOLE.
223
Reports of Mobility decreased with LANSOPRAZOLE
0.4%
of all LANSOPRAZOLE reports
132
Deaths
213
Hospitalizations
How Dangerous Is Mobility decreased From LANSOPRAZOLE?
Of the 223 reports, 132 (59.2%) resulted in death, 213 (95.5%) required hospitalization, and 137 (61.4%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANSOPRAZOLE. However, 223 reports have been filed with the FAERS database.
What Other Side Effects Does LANSOPRAZOLE Cause?
Chronic kidney disease (32,517)
Acute kidney injury (16,359)
Renal failure (12,509)
End stage renal disease (9,734)
Renal injury (9,383)
Tubulointerstitial nephritis (3,860)
Death (2,517)
Gastrooesophageal reflux disease (2,482)
Off label use (2,183)
Nephrogenic anaemia (2,162)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which LANSOPRAZOLE Alternatives Have Lower Mobility decreased Risk?
LANSOPRAZOLE vs LANTHANUM
LANSOPRAZOLE vs LANTUS
LANSOPRAZOLE vs LANTUS SOLOSTAR
LANSOPRAZOLE vs LAPATINIB
LANSOPRAZOLE vs LAPATINIB DITOSYLATE